Aller au contenu principal
Profil bibliographique

Yuval Ishay

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

37Publications signalées
370Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLiver Disease Diagnosis and TreatmentGastrointestinal motility and disordersSphingolipid Metabolism and Signaling

Les publications récentes

Accès ouvert 2026 article OpenAlex

The Management of Irritable Bowel Syndrome

Fahmi Shibli, Roy Dekel, Ron Yishai, Joseph Lysy et autres

Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction with symptoms including abdominal pain associated with a change in stool form or frequency. IBS global prevalence is around 4% and its impact on patient's quality of life and social functioning is …

il, gb (code pays fourni par la source)

1 citation Journal of Clinical Gastroenterology
Accès ouvert 2025 article OpenAlex

Sleeve gastrectomy reveals the plasticity of the human gastric epithelium

Amit Elad, Botros Moalem, Dana Sender, Aya Bardugo et autres

Gastrin is secreted following a rise in gastric pH, leading to gastric acid secretion. Sleeve gastrectomy (SG), a bariatric surgery where 80% of the gastric corpus is excised, presents a challenge for gastric pH homeostasis. Using histology, and single-cell RNA sequencing of …

il, us, ch (code pays fourni par la source)

9 citations Nature Communications
Accès ouvert 2024 article OpenAlex

Investigating the Relationship between Chronic Liver Cirrhosis and Parkinsonism: A Comparative Analysis and a Suggested Diagnostic Scheme

Tal Sigawi, Omer Hamtzany, Noa Hurvitz, Yuval Ishay et autres

Aim: Neurological manifestations are common in patients with chronic liver diseases. This study aimed to depict the association between liver cirrhosis and Parkinson’s disease (PD) and propose a clinically relevant diagnostic scheme. Methods: We examined patients’ medical records with PD and chronic …

il (code pays fourni par la source)

3 citations Clinics and Practice
Accès ouvert 2023 article OpenAlex

Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical Trial

Yuval Ishay, Joel Neutel, Yotam Kolben, Ram Gelman et autres

Background and Aims: Metabolic dysfunction-associated steatohepatitis is an advanced form of nonalcoholic fatty liver disease and a leading cause of end-stage liver disease and transplantation. Insulin resistance and inflammation underlie the pathogenesis of the disease. Methods: This double-blind, randomized, placebo-controlled, multicenter feasibility …

il, us (code pays fourni par la source)

3 citations Gastro Hep Advances
Accès ouvert 2023 article OpenAlex

Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis

David Hakimian, Johnny Amer, Alaa Jammal, Asher Shafrir et autres

SARS-CoV-2 vaccine responses that could harbor potential risks to chronic liver diseased patients. To assess immune response following Pfizer's SARS-CoV-2 vaccine in patients with different liver fibrosis severities of nonalcoholic fatty liver disease (NAFLD). Clinical and histological (NAS-score and fibrosis stage) characteristics …

il, us (code pays fourni par la source)

1 citation Vaccine X
2023 article OpenAlex

98-OR: Oral Insulin Alleviates Liver Fibrosis and Reduces Fat in Patients with NASH and Type 2 Diabetes—Results of Phase II Clinical Trial

Yuval Ishay, Joel M. Neutel, Yotam Kolben, Ram Gelman et autres

NAFLD is the most common liver disorder in the USA. NASH is an advanced form of NAFLD and a leading cause of end-stage liver disease and indication for liver transplantation. Insulin resistance and inflammation underlie the pathogenesis of the disease. This double-blind, …

0 citations Diabetes
Accès ouvert 2023 article OpenAlex

Serum Levels of Adropin Improve the Predictability of MELD and Child-Pugh Score in Cirrhosis: Results of Proof-of-Concept Clinical Trial

Yotam Kolben, Ariel Kenig, Asa Kessler, Yuval Ishay et autres

Adropin is a peptide that was suggested to have a role in cirrhosis. The present study aimed to determine the ability to use serum adropin levels to improve their prediction accuracy as an adjunct to the current scores. In a single-center, proof-of-concept …

il (code pays fourni par la source)

7 citations Transplant International
Accès ouvert 2022 article OpenAlex

Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center Experience

Yuval Ishay, Ariel Kenig, Limor Rubin, Oded Shamriz et autres

The association between infectious diseases and autoimmunity has long been reported. Specifically, during the coronavirus disease 2019 (COVID-19) pandemic, this relation was further emphasized. The interplay between the two disease processes remains interesting, yet incompletely defined. Herein, we report a case series …

il (code pays fourni par la source)

5 citations Autoimmune Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.